Zobrazeno 1 - 10
of 53
pro vyhledávání: '"Ryunosuke Machida"'
Autor:
Momoko Tokura, Mark Malalay Ando, Yuki Kojima, Rui Kitadai, Shu Yazaki, Cyrielle Marie N Atutubo, Rubi K. Li, Minda Z. Perez, Agnes E Gorospe, Manuelito A Madrid, Mel Valerie C Ordinario, Marcelo Severino B Imasa, Kazuki Sudo, Tatsunori Shimoi, Akihiko Suto, Shinji Kohsaka, Ryunosuke Machida, Ryo Sadachi, Masayuki Yoshida, Yasushi Yatabe, Tomomi Hata, Kenichi Nakamura, Kan Yonemori, Sho Shiino
Publikováno v:
Breast Cancer: Basic and Clinical Research, Vol 18 (2024)
Background: Biomarkers to predict the recurrence risk are required to optimize perioperative treatment. Adjuvant chemotherapy for patients with human epidermal growth factor 2-positive (HER2-positive) early breast cancer is decided by pathological re
Externí odkaz:
https://doaj.org/article/8a7f3f576e954395859449aabb804cb6
Autor:
Tomoya Yokota, Sadamoto Zenda, Takeshi Kodaira, Naomi Kiyota, Yasushi Fujimoto, Koichiro Wasano, Ryo Takahashi, Takashi Mizowaki, Akihiro Homma, Keita Sasaki, Ryunosuke Machida, Yuta Sekino, Haruhiko Fukuda, Japan Clinical Oncology Group Radiation Therapy Study Group, Japan Clinical Oncology Group Head and Neck Cancer Study Group
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-9 (2023)
Abstract Background Chemoradiotherapy (CRT) with concurrent cisplatin is the standard of care as a nonsurgical definitive treatment for patients with locally advanced squamous cell carcinoma of the head and neck (LA-SCCHN). However, CRT is associated
Externí odkaz:
https://doaj.org/article/64f26ab6387144ab912b9f48270258b6
Autor:
Makoto Endo, Tomoko Kataoka, Toshifumi Fujiwara, Satoshi Tsukushi, Masanobu Takahashi, Eisuke Kobayashi, Yoko Yamada, Takaaki Tanaka, Yutaka Nezu, Hiroaki Hiraga, Junji Wasa, Akihito Nagano, Kenji Nakano, Robert Nakayama, Tetsuya Hamada, Masanori Kawano, Tomoaki Torigoe, Akio Sakamoto, Kunihiro Asanuma, Takeshi Morii, Ryunosuke Machida, Yuta Sekino, Haruhiko Fukuda, Yoshinao Oda, Toshifumi Ozaki, Kazuhiro Tanaka
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-8 (2023)
Abstract Background Soft tissue sarcomas (STS) are a rare type of malignancy comprising a variety of histological diagnoses. Chemotherapy constitutes the standard treatment for advanced STS. Doxorubicin-based regimens, which include the administratio
Externí odkaz:
https://doaj.org/article/fbc2c36541c844a2894c17228bd7e226
Autor:
Isao Yoshida, Ken Ohmachi, Naomi Konishi, Ryunosuke Machida, Dai Maruyama, Wataru Munakata, Tsutomu Kobayashi, Tomohiro Kinoshita, Kiyoshi Ando, Hirokazu Nagai
Publikováno v:
HemaSphere, Vol 7, p e8882877 (2023)
Externí odkaz:
https://doaj.org/article/5a94517fe512462fada746f9fef7edac
Autor:
Yohei Chiba, Kazuki Sudo, Yuki Kojima, Hitomi Okuma, Shinji Kohsaka, Ryunosuke Machida, Masahiko Ichimura, Kenta Anjo, Kazumi Kurishita, Natsuko Okita, Kenichi Nakamura, Ichiro Kinoshita, Masanobu Takahashi, Junichi Matsubara, Hitoshi Kusaba, Kan Yonemori, Masamichi Takahashi
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-7 (2022)
Abstract Background Aberrant fibroblast growth factor receptor (FGFR) signaling can substantially influence oncogenicity. Despite that FGFR gene abnormality is often detected by cancer genome profiling tests, there is no tumor-agnostic approval yet f
Externí odkaz:
https://doaj.org/article/b9a9bead250a4d37a94ada3f00650579
Autor:
Tadaaki Nishikawa, Kosei Hasegawa, Koji Matsumoto, Masahiko Mori, Yasuyuki Hirashima, Kazuhiro Takehara, Kazuya Ariyoshi, Tomoyasu Kato, Shigehiro Yagishita, Akinobu Hamada, Mamiko Kawasaki, Satoshi Kawashima, Sawako Tomatsuri, Yukari Nagasaka, Hiroshi Yoshida, Ryunosuke Machida, Akihiro Hirakawa, Kenichi Nakamura, Kan Yonemori
Publikováno v:
Journal of Clinical Oncology. 41:2789-2799
PURPOSE To investigate the efficacy and safety of trastuzumab deruxtecan, an antibody-drug conjugate targeting human epidermal growth factor receptor 2 (HER2) with a topoisomerase I inhibitor payload, in patients with uterine carcinosarcoma (UCS) exp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e134da79f4b01eb26c814bc2c81100a3
https://doi.org/10.1200/jco.22.02558
https://doi.org/10.1200/jco.22.02558
Autor:
Hiroya, Takeuchi, Yoshinori, Ito, Ryunosuke, Machida, Ken, Kato, Masakatsu, Onozawa, Keiko, Minashi, Tomonori, Yano, Kenichi, Nakamura, Takahiro, Tsushima, Hiroki, Hara, Tatsuya, Okuno, Shuichi, Hironaka, Isao, Nozaki, Takashi, Ura, Keisho, Chin, Takashi, Kojima, Shiko, Seki, Katsuyuki, Sakanaka, Haruhiko, Fukuda, Yuko, Kitagawa
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 114:454-462
Definitive chemoradiotherapy (CRT) is the standard treatment for patients with locally advanced esophageal cancer (EC) who refuse surgery as the initial therapy. However, poor survival, a high incidence of late toxicities, and severe complications af
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c93409705b3582637b159ada3dd0ec5b
https://doi.org/10.1016/j.ijrobp.2022.07.007
https://doi.org/10.1016/j.ijrobp.2022.07.007
Autor:
Kazuhiro Tanaka, Ryunosuke Machida, Akira Kawai, Robert Nakayama, Satoshi Tsukushi, Kunihiro Asanuma, Yoshihiro Matsumoto, Hiroaki Hiraga, Koji Hiraoka, Munenori Watanuki, Tsukasa Yonemoto, Satoshi Abe, Hirohisa Katagiri, Yoshihiro Nishida, Akihito Nagano, Yoshiyuki Suehara, Hiroyuki Kawashima, Masanori Kawano, Takeshi Morii, Hiroshi Hatano, Junya Toguchida, Tomotake Okuma, Masanobu Takeyama, Satoshi Takenaka, Toshihiro Akisue, Taisuke Furuta, Makoto Emori, Toru Hiruma, Hidetatsu Outani, Tetsuji Yamamoto, Tomoko Kataoka, Haruhiko Fukuda, Toshifumi Ozaki, Yukihide Iwamoto
Publikováno v:
British Journal of Cancer. 127:1487-1496
Background This randomised phase II/III trial aimed to determine whether perioperative chemotherapy with gemcitabine plus docetaxel (GD) is non-inferior to the standard Adriamycin plus ifosfamide (AI) in terms of overall survival (OS) in patients wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::809e411b1df801edfeb02c59b42a1154
https://doi.org/10.1038/s41416-022-01912-5
https://doi.org/10.1038/s41416-022-01912-5
Autor:
Haruhiko Fukuda, Akiko Hasegawa, Hitoshi Mizutani, Hirokazu Shoji, Tatsuya Takenouchi, Tetsuya Hamaguchi, Taro Shibata, Naoya Yamazaki, Tomohiro Nishina, Keiko Nozawa, Atsuo Takashima, Toshiki Masuishi, Narikazu Boku, Shusuke Yoshikawa, Akihito Kawazoe, Sumiko Takatsuka, Ryunosuke Machida, Yoshio Kiyohara, Katsuko Kikuchi, Masanobu Takahashi
Publikováno v:
Supportive Care in Cancer. 30:4497-4504
Background: Althoughpre-emptive therapy with oral tetracycline, moisturizer, sunscreen and topical corticosteroid isuseful for preventing acneiform eruption (AfE) due to epidermal growth factor receptor (EGFR) inhibitors, no studies have examinedthe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a892219097c8810bff5dc63fa3bf1b87
https://doi.org/10.1007/s00520-022-06874-1
https://doi.org/10.1007/s00520-022-06874-1
Autor:
Tomotaka Suzuki, Dai Maruyama, Ryunosuke Machida, Tomoko Kataoka, Noriyasu Fukushima, Nobuyuki Takayama, Rie Ohba, Ken Omachi, Yoshitaka Imaizumi, Masahito Tokunaga, Hiroo Katsuya, Isao Yoshida, Kazutaka Sunami, Mitsutoshi Kurosawa, Nobuko Kubota, Hiroaki Morimoto, Miki Kobayashi, Kazuhito Yamamoto, Yoshihiro Kameoka, Yoshitoyo Kagami, Takayuki Tabayashi, Masaki Maruta, Tsutomu Kobayashi, Shinsuke Iida, Hirokazu Nagai
Publikováno v:
Hematological Oncology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7df37ff7b91c4b1cef487af49847ca06
https://doi.org/10.1002/hon.3103
https://doi.org/10.1002/hon.3103